Clinical trial results show a nasal spray treatment for acute migraine helps more users achieve relief from pain within two hours, and faster in some cases. . . . → Read More: Trial Shows Nasal Spray Relieves Migraine Pain
|
|||||
       
  |
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases 
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics. . . . → Read More: $180M Venture Fund Backing Age-Related Disease Start-Ups 
A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy. . . . → Read More: Covid-19 Antibody Cocktail Trial Request Filed 
A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round. . . . → Read More: Plant-Based Protein Biotech Raises $3M in Seed Funds 
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production 
A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, cancer, Covid-19, equity, Europe, investment, licensing, life sciences, pharmaceuticals 
A clinical trial completed enrollment of lung cancer patients testing a device sending an electric field into their tumors to disrupt cancer cell proliferation. . . . → Read More: Trial Advances Test of Electronic Cancer Treatment Comments are closed New products biomedical, cancer, chemistry, clinical trials, engineering, life sciences, medical device, pharmaceuticals, physical sciences, physics, university 
A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding. . . . → Read More: Cell Therapy Start-Up Raises $6M in Seed Funds Comments are closed Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, life sciences, manufacturing, pharmaceuticals, stem cells, venture capital 
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion. . . . → Read More: Novo Nordisk Buys RNA Biotech in $3.3B Deal Comments are closed Finance biomedical, biotechnology, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
